Blog: Research

Grant from MS Society, Parkinson’s UK to Establish Digital Brain Bank

15 August 2019

Source Parkinson's News Today: The Multiple Sclerosis (MS) and Parkinson’s Tissue Bank at Imperial College London, is the largest repository of brain and spinal cord tissue samples in Europe.

NICE rejects Sativex in draft guidance on cannabis-based medicinal products

15 August 2019

Source MS Trust: Draft guidance published today on August 8 does not recommend Sativex as a treatment for MS spasticity because it is not a cost-effective treatment.

Research request from Kings College London

30 July 2019

Source Kings College London: "I am a third-year psychology student at King’s College London, currently assisting a PhD student, Jowinn Chew (cc'd in this email), on her research supervised by Dr Colette Hirsch and Prof Rona Moss-Morris from the Health Psychology Department. The research is focusing on identifying the cognitive mechanisms which underpin and maintain anxiety surrounding illness uncertainty within MS.

Early MS scans 'can predict long-term prognosis'

30 July 2019

Source BBC: Scans carried out when someone is first diagnosed with multiple sclerosis can predict their long-term prognosis, research has shown.

MS: Drugs trial hope for multiple sclerosis patients

30 July 2019

Source BBC: Welsh patients are taking part in a drugs trial aimed at slowing late-stage multiple sclerosis progression.

Phase 3 Trial of Ibudilast Planned for SPMS Patients with Inactive Disease, MediciNova Says

23 July 2019

Source Medical News Toady: A Phase 3 trial is planned to confirm the safety and efficacy of oral ibudilast (MN-166) in treating people with secondary progressive multiple sclerosis (SPMS) without relapses or those whose disease is not active, MediciNova announced.

Scientists have discovered that a specific brain cell known as a 'projection neuron' has a central role to play in the brain changes seen in multiple sclerosis (MS).

23 July 2019

Source Science Daily: The research shows that projection neurons are damaged by the body's own immune cells and that this damage could underpin the brain shrinkage and cognitive changes associated with MS. These new findings provide a platform for specific new MS therapies that target damaged brain cells to be developed.

Scientists Identify Differences Between Relapsing/Remitting and Progressive Multiple Sclerosis

23 July 2019

Source BioSpace: Multiple sclerosis (MS) is an often-disabling disease of the central nervous system caused by damage to the myelin coating around the nerves.

3-D Brain Models of PPMS and Parkinson’s Off to Space Station for Research in Microgravity

23 July 2019

Source Multiple Sclerosis News Today: The National Stem Cell Foundation (NSCF) announced the start of a pioneering project to investigate the impact of microgravity on the neurodegeneration associated with primary progressive multiple sclerosis (PPMS) and Parkinson’s disease.

Pages

Category

Archive